Sofinnova Venture Partners IX, L.P., 10% Owner at NextCure, Inc. (NXTC), bought 150,000 shares at $36.75 ($5.5M) on 2019-11-15, disclosed to the SEC on 2019-11-19.
Open-market purchase of $5.5M NXTC by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| Filing → |
| ITRM | BUY | 2018-05-30 | $6.5M | — | Filing → |